Nonin Medical names new CEO
By HME News Staff
Updated 9:12 AM CST, Tue November 25, 2025
MINNEAPOLIS – Nonin Medical’s board of directors has appointed medical device industry leader Todd Austin as its next CEO. Prior to joining Nonin Medical, Austin served as president and CEO of MGC Diagnostics, a subsidiary of CAIRE and Niterra. Prior to that, he held the role of executive vice president, global marketing, engineering, and corporate strategy at MGC Diagnostics. “Todd’s deep expertise in respiratory diagnostics and proven record of strategic leadership make him the ideal person to guide Nonin into its next phase of growth,” said Phil Isaacson, executive chairman, board of directors, at Nonin Medical. “His passion for innovation in the respiratory medical device industry and commitment to advancing patient outcomes align perfectly with Nonin’s mission and values.” Austin’s career also includes key leadership roles at Angeion, CareFusion, NDD, VIASYS Healthcare and SensorMedics. He is a registered respiratory therapist (RRT), registered pulmonary function technologist (RPFT) and neonatal-pediatric specialist (NPS). “Throughout my 30-plus years as a respiratory therapist, I’ve trusted and relied on Nonin’s products and technology across nearly every care setting – from bedside and critical care to transport, sleep and cardiopulmonary diagnostics, remote monitoring, and device integration,” said Austin. “Nonin has always stood for quality, reliability, and innovation, values that have guided my own career.”
Comments